State health officials this week confirmed a case of mpox in an adult Anchorage resident with a history of recent out-of-state travel.

The Alaska Section of Epidemiology said no additional cases or evidence of local community transmission were identified as of Monday, according to a public health alert.

The patient, who is isolating and recovering at home, was unvaccinated and had traveled where ongoing mpox activity has been reported, according to the alert. Close contacts to the Alaskan patient have been identified and are undergoing notification, risk assessment and monitoring, officials said.

Mpox is spread through physical contact with an infected individual, contaminated materials, or infected animals, and can last two to four weeks, according to the World Health Organization.

Mpox, which has an incubation period ranging from three to 17 days, becomes infectious at the onset of symptoms, such as fever, chills, fatigue, lesions and rash, according to the health alert. Lesions can commonly be found on the hands, feet, face, chest or genital area.

Alaska reported its first case of mpox in 2022. The ongoing global outbreak of clade II mpox has resulted in more than 100,000 cases in 122 countries, according to the Centers for Disease Control and Prevention. While there is no specific treatment for mpox, both preventative pre-exposure and post-exposure vaccination are available, officials say.

Health officials said anyone with questions or the need to report a possible case of mpox can contact the Section of Epidemiology at 907-269-8000, or a 24-hour emergency line at 1-800-478-0084.

©2025 Anchorage Daily News. Visit at adn.com. Distributed by Tribune Content Agency, LLC.